ABCDEFGHIJKLMNOPQRST
1
Israel Digital Health Delegation to JPM Week 2022
2
CompanyOne-linerDescriptionTech TagsTherapeutic areasCompany stageFunding raised (USD)Revenue (USD)Notable customers/partnersLooking to raise (USD)FDA approval or clearanceUS presenceDeckProduct Demo
3
AgamonPowering data-driven healthcare, where no patient falls through the cracksPowered by proprietary Natural Language Processing, Agamon technology can increase early detection of disease, detect follow-up recommendations in radiology reports, notifies the necessary people at the right time and tracks whether a patient has returned for their exams/follow-up appointments.Artificial Intelligence, Clinical Document Management, Hospital Operational EfficiencyGeneral Health, OncologyInitial Revenues$3.5M from MMC, Inhealth Ventures, Seedcamp and Bayer plus $500k grant from the IIAYes, to be shared during the meetingHenry Ford Health System, Jefferson Health System, Main Street Radiology$8MNot requiredUS office in Atlanta where our GM US is basedLinkLink
4
DayTwoMicrobiome-based precision nutrition for metabolic diseaseDayTwo uses the worlds most advanced proprietary microbiome science with access to the largest dataset to provide precision nutrition. DayTwo uses gut microbiome profiling and artificial intelligence to predict blood sugar response to foods and provide dedicated virtual care. Telehealth provides virtual care by registered dietitian Clinical & science based- published in peer reviewed journals our clinical study with significant results. The technology also tracks exams/follow-up appointments.Nutrition Tech, Precision / Personalized Medicine, Telemedicine SolutionsDiabetics, Metabolic Diseases, ObesityRevenue Growth~$85MYes, to be shared during the meetingUnited , Cigna$20-30MNot requiredYes. Office in CA & Nusville, ~50 employees in USLinkLink
5
DiA Imaging AnalysisEmpowering Ultrasound Users with AI software solutionsDiA Imaging Analysis makes the use and analysis of ultrasound images smarter and accessible to all through the addition of AI-based technology. Instead of the subjective visual analysis performed currently, DiA’s Al-based solutions enable users to identify clinical indications and abnormalities objectively and accurately.Artificial Intelligence, Decision Support Systems, Digital ImagingCardiovascular, Intensive Care, Primary CareInitial Revenues25Myes, disclosed upon meetingn/a30MYesYesLinkLink
6
Donisi HealthAt home contact-free technology to remotely detect signs of pulmonary congestion and other parameters for heart failure.Donisi has the only clinically validated contact-free technology that can remotely detect signs of pulmonary congestion and additional parameters key for heart failure exacerbation detection in the home.Decision Support Systems, Remote Monitoring, Telemedicine SolutionsCardiovascularInitial Revenues$27MNoDell, NUHS$15MYesYes - one and growing!Linkn/a
7
DreaMed DiabetesAI-based decision support system for optimal diabetes treatmentDreaMed Diabetes’ endo.digital platform uses the company’s MD Logic algorithm to solve the massive lack of endocrinologists in the world and to provide ongoing diabetes expert care. Designed by premier endocrinologists, based on real-world evidence and charged by artificial intelligence, DreaMed is the only FDA-cleared software to manage and monitor diabetes by reading and analyzing continuous glucose monitors. The proprietary AI-based decision support system enables endocrinologists and non-specialists to rapidly prescribe recommended insulin doses.Artificial Intelligence, Decision Support Systems, Precision / Personalized MedicineDiabetics, EndocrinologyInitial Revenues$2 Medtronic Diabetes, $3M Roman Abramovithc, $1.1M OurCrowd, $4.5M grant from the Helmsley Charitable Trustyes, 2022 contract signed 1MBoston Children's$6-$10MYesWe have a US subsidiary entity with 2-5 employeesLinkLink
8
EyeControlICU communication platform enabling connectivity between ventilated patients, medical teams, and families.EyeControl-Med is a communication solution for ICUs, enabling connectivity between patients who cannot speak, medical teams, and families. EyeControl-Med provides medical insight that enhances treatment accuracy, while increasing patient engagement. With the potential to manage Delirium, EyeControl-Med may decrease hospital costs and length of stay.Artificial Intelligence, Nursing Applications, Wearables & IOTIntensive Care, Neuroscience, RespiratoryInitial revenues and clinical trials.$15MYes, to be shared during the meetingIsraeli Health Basket, Clalit, NHS$15MYesOffice and 2 team members.LinkLink
9
Geneyx Genomex LtdA superior Clinical Genetic data analysis, secure storage and management softwareGeneyx offers a superior NGS data analysis and interpretation platform, harnessing genetic data to guide digital insights for rare and germline disorders.The AI-based analysis platform streamlines the diagnostics process, from the raw genetic data to the final clinical report. Geneyx develops unique technologies and utilizes diverse databases in the interpretation of WGS (Whole Genome Sequencing), WES, and gene panels.Decision Support Systems, Hospital Operational Efficiency, Precision / Personalized MedicineCardiovascular, Genetic Disorders, PediatricsRevenue Growth$10 M - Next leap venture, Capri ventures, Accenture venturesyes, 750kAccenture - life science division, Bambino Gesu children hospital, (Rome) Son Espace hospital (Spain)$10MNot requiredGeneyx INC. 1013 Centre Road, Suite 403-B Wilmington, DE USA 19805, 4 employeesLinkLink
10
MedAwareAI-Powered Medication Safety PlatformMedAware's AI-powered medication safety monitoring platform identifies dangerous medication-related risks throughout the entire patient journey. The platform lives within existing technology systems, EHRs, and other devices. Built using longitudinal and real-time patient data, advanced machine learning algorithms identify medication errors, opioid dependency risk, evolving adverse drug events, drug-drug interactions and more. Founded in 2012, MedAware has offices in the United States and Israel.Artificial Intelligence, Decision Support Systems, Population Health ManagementGeneral Health, Internal Medicine, Primary CareRevenue Growth$20m OurCrowd, Qure Ventures, Winton Ventures, Gefen CapitalYes, to be shared during the meetingBaxter, Sheba Medical Center, athenahealth$10MNot RequiredNoLinkLink
11
MedorionPlatform that learns members health behaviors and creates personalized programs/assistance based on this data.The Health Behavior Management Platform enables health organizations to understand “real life” health behavior scenarios and manage every interaction with a member based on that Health report. These capabilities enable solving gaps in healthcare outcomes and improving the well-being of millions of individuals.Artificial Intelligence, Population Health ManagementGeneral HealthProof of Concept$9M: 10D, TAU Ventures, iAngelsyes, 2-3MAdvantasure, BCBSMI, Pfizer Inc,$15MNot requiredMedorion Technologies Inc, 3 employeesLinkn/a
12
NewstemProprietary Robust Bio-Platform for drug discoveryNewStem possess a proprietary and patented Haploid human Embryonic Stem Cells (HhESC) Atlas. This technology is the most Robust Tool for Genetic Screening. Utilizing this un-biased platform, the company is focused on developing cancer therapeutics based on Novel Targets for Synthetic Lethal InteractionPrecision / Personalized MedicineOncologyR&D$4M NovelStemNoIllumina$10MNon/aLinkLink
13
Olive DiagosticsFirst at home handsfree passve urinalysis device that enables continous monitoring A noninvasive passive urinalysis sensor that provides real-time health alerts, early detection, and information on disease progression. Using optics for data collection, the sensor is mounted inside the toilet and does not require further intervention.home health, wellness, urinalysis, IoT, Chronic disease
management
Round Adisclosed upon meetingNoIsrael Innovation Authority, Cleveland Clinic, Amgen, Maccabi Healthcare, Services, eHealth Venturesdisclosed upon meetingTechnostat (3rd party validation), ISO 13485 CertifiedComing Soon!LinkPlease Schedule
14
OncoHostBlood-sample based profiling platform that predicts patient’s response to treatmentOncoHost developed a differentiated approach to precision oncology with excellent clinical results, significant value proposition and a working business model. OncoHost is supported by a world class SAB and experienced management. Commercial launch in the US at Q2 22Artificial Intelligence, Decision Support Systems, Precision / Personalized MedicineOncologyClinical Trials$15MNoCMEH, TRDF, Glenrock, Value acceleration group inc.$25Not RequiredNoLinkLink
15
OwlyticsValidated Personal health analytics and triage based on off-the-shelf wearablesPredictive and personalized health analytics B2B service, supporting home health providers of fragile seniors, degenerative neurology patients and rehab patients. This technology continuously tracks the personal physiology/ activity/ gait/ fall and risk patterns of individuals, creating a powerful tool for risk management, indoor and outdoor. Our cloud-based predictive analytics were developed and validated in an academic center specializing in Neurodynamic and Fall risk management. Initial US market traction is also supported by CMS RPM & RTM reimbursement.Artificial Intelligence, Remote Monitoring, Wearables & IOTNeurology and Degenerative Disease, Primary Care, RehabilitationInitial Revenues$6M funding +$2M grants. Investors: Halma CVC, CBG PE, Dovel Group, Mike Bermanyes, 500KCareOne, Parkinson Pharma Company, LinkHome Therapy, BT, Centrak, Sheba Medical Center, Tel-Aviv Medical Center, Israeli HC Ministry$10MYes, Neuro Progression 510k- End of 2022Boston, #3 BD/ Sales TeamLinkLink
16
Virility Medical LtdA consumer healthcare startup, focused on commercialization of sexual wellbeing products.The product is the world’s first wearable, drug-free, single-use, discreet skin patch with an immediate effect of delaying ejaculation. Applied to the male perineum during intercourse, it delivers short-duration, low-intensity electrical stimulation, which enhances the strength and duration of volitional pelvic-floor muscle contractions, intended to delay ejaculation. The patch has been cleared by FDA and is CE-marked. Patents has been granted in the US, China, Japan and Australia.Proactive welless/Lifestyle/Patient Engagment, Wearables & IOTUrologyRegulatory ApprovalUSD 10M from Atkin Holdings https://www.arkinholdings.com/NoUSD 30M Series BYesComing Soon!LinkLink
17
Xtrodesbio-convergence company, the developer of the first scalable wireless Smart SkinX-trodes aims to reduce hospitals workload through a medical technology that provides advanced electrophysiological monitoring and analytics in patient’s natural environment. X-trodes Smart Skin, precisely and seamlessly provides multimodality measurements (EEG, ECG and EMG signals) and provides real-time display of the acquired signals through a single patch.Artificial Intelligence, Remote Monitoring, Telemedicine SolutionsNeurology and Degenerative Disease, NeuroscienceSeed4.7Myes, 500kN/A10MIn 9-12 monthsNoLinkn/a
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100